Sun, Mar 29, 2020
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Barclay Hedge Fund Index gains 0.54% in July

Tuesday, August 14, 2018

Matthias Knab, Opalesque:

Hedge Funds gained 0.54% in July according to the Barclay Hedge Fund Index compiled by BarclayHedge, versus a 3.72% increase in the S&P 500 Total Return Index. Year to date, the Barclay Index is up 1.04%, while the S&P has gained 6.47%.

"In spite of July's rise in global equities, hedge fund performance was mixed," says Sol Waksman, founder and president of BarclayHedge.

Twelve of Barclay's 17 hedge fund indices gained ground in July, while five had losses. The Healthcare & Biotechnology Index was up 1.83%, Equity Long Bias scored a 1.52% gain, European Equities were up 0.73%, while Emerging Markets ended their five-month losing streak with a 0.22% gain.

The Technology Index fell 0.95% in July, Pacific Rim Equities were down 0.79%, Global Macro lost 0.61%, and Merger Arbitrage gave up 0.38%.

"Technology funds were negatively impacted by Facebook's record 20 percent decline triggered by the announcement of weaker-than-expected revenue growth," says Waksman. "Based on Q1 13F filings, Facebook was the third most widely-held stock in hedge fund portfolios. Microsoft was the most popular and Google was second."

After seven months, 12 hedge fund indices have gains in 2018, while five have negative returns for the year. Healthcare & Biotechnology continues its strong performance with an 11.70% year-to-date gain. Distressed Securities are up 6.96%, the Technology Index has gained 6.22%, and European Equities are up 3.32%.

The Emerg......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. PE/VC: Unicorns sometimes sting, Private equity at crossroads as rout offers deals, curbs lending, S&P survey shows sagging prospects for private equity[more]

    Unicorns sometimes sting From Venture capital firms are on a roll. Some 259 U.S. venture capital funds amassed $46.3 billion in 2019, the second highest by amount of capital raised and number of funds since 2006, according to the PitchBook-NVCA Venture Monitor. The biggest f

  2. Study: Three threats to hedge funds, Institutions seeing more private credit risks[more]

    Three threats to hedge funds From All About Alpha: A recent paper by a scholar at Tilburg University and a market participant at Robeco outlines the difficulties that the hedge fund industry has faced over the last decade. These problems arose, at least in part, from the democratization o

  3. Hedge fund Solus to close flagship investment vehicle[more]

    From FT: Solus Alternative Asset Management, one of the best known specialists in distressed investments, is closing its flagship fund after suffering a combination of heavy redemptions and poor performance. The hedge fund, which as recently as November managed $4.3bn in assets, is one of the fi

  4. Coronavirus 'possibly the biggest economic event of all our lifetimes', 'Big short' Michael Burry has a bearish bet and warns of a selling stampede, Investors' Black Death fear driving panic, says Witan Investment Trust chief Andrew Bell[more]

    Coronavirus 'possibly the biggest economic event of all our lifetimes' A former macro fund manager said on Thursday that the economic impact of the coronavirus - which is shaving trillions off the stock market and exerting a domino effect on the world economy - might be even worse than th

  5. Investing: As markets plunge, short sellers make hay, Time to buy, says GMO[more]

    As markets plunge, short sellers make hay From Institutional Investor: Short sellers floundered during the bull market. But as the market tides have turned, so too have their fortunes. "Some people haven't invested in hedge funds for a very long time," said Mark Roberts, owner of sh